Beil W, Sewing K F
Br J Pharmacol. 1984 Jul;82(3):651-7. doi: 10.1111/j.1476-5381.1984.tb10803.x.
The cellular and subcellular distributions of adenosinetriphosphatases (ATPases) were examined in guinea-pig gastric mucosal cells. All cell types displayed Mg2+-ATPase and bicarbonate (HCO3-)-stimulated ATPase activity. K+-ATPase was located only in fractions derived from parietal cells. Differential and density-gradient centrifugation of material prepared from parietal cells revealed that K+-ATPase activity was located in a tubulo-vesicular membrane fraction. Enzyme activity was ten fold greater in this fraction than in a crude parietal cell homogenate. The substituted benzimidazoles, omeprazole and picoprazole, inhibited K+-ATPase (IC50 1.8 +/- 0.5 mumol l-1 and 3.1 +/- 0.4 mumol l-1, respectively). Detailed kinetic analysis indicated that these compounds were non-competitive and reversible inhibitors of the enzyme. In contrast cimetidine and verapamil were without effect on the enzyme. The relevance of the inhibition of K+-ATPase to the antisecretory activity of the benzimidazoles, in experimental animals and man, is discussed.
研究了豚鼠胃黏膜细胞中三磷酸腺苷酶(ATP酶)的细胞和亚细胞分布。所有细胞类型均显示出镁离子ATP酶和碳酸氢盐(HCO3-)刺激的ATP酶活性。钾离子ATP酶仅位于壁细胞来源的组分中。对壁细胞制备的材料进行差速离心和密度梯度离心后发现,钾离子ATP酶活性位于微管泡膜组分中。该组分中的酶活性比壁细胞粗匀浆中的酶活性高10倍。取代苯并咪唑类药物奥美拉唑和吡考拉唑可抑制钾离子ATP酶(IC50分别为1.8±0.5μmol l-1和3.1±0.4μmol l-1)。详细的动力学分析表明,这些化合物是该酶的非竞争性可逆抑制剂。相比之下,西咪替丁和维拉帕米对该酶无作用。本文讨论了在实验动物和人类中,抑制钾离子ATP酶与苯并咪唑类药物抗分泌活性的相关性。